4.38 USD
↗ 0.14 (3.35%)LIVE (AS OF 01:23 PM EDT)
Bicycle Therapeutics plc American Depositary Shares
BCYCNASDAQ • USD
Market: OPEN
BCYC is currently priced at $4.38. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics suggest BCYC is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Aug 20, 2026.
Open?$4.29
High?$4.51
Low?$4.18
Prev. Close?$4.24
Volume?358.5K
Avg. Volume?321.5K
VWAP?$4.41
Rel. Volume?1.12x
Bid / Ask
Bid?$4.37 × 900
Ask?$4.38 × 700
Spread?$0.01
Midpoint?$4.38
Valuation & Ratios
Market Cap?296.8M
Shares Out?50.6M
P/E Ratio?N/A
P/B Ratio?0.58
EPS?-$2.72
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.
Employees
288
Market Cap
289.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2019-05-23
Address
BLOCKS A & B, PORTWAY BUILDING
CAMBRIDGE, X0 CB21 6GS
Phone: 011441223261503
CAMBRIDGE, X0 CB21 6GS
Phone: 011441223261503
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?1
Momentum?65
Short Sent.?34
Piotroski F-Score?3/9Weak
Altman Z-Score?-0.48Distress
Confidence?58%Low
Short InterestHigh
Short Interest?3.0M
Days to Cover?9.9
Avg Daily Volume301.9K
Settlement Date2026-07-31
Financial Health
Current Ratio?12.08Strong
Quick Ratio?12.08Strong
Cash Ratio?10.71Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score92/100
P/E?N/A▾
P/B?0.58CHEAP▾
Peers100
S&P97
P/S?4.85FAIR▾
Peers100
S&P30
P/FCF?N/A▾
EV/EBITDA?1.0CHEAP▾
Peers100
S&P97
EV/Sales?-3.48CHEAP▾
S&P97
Returns & Efficiency
ROE?-37.3%WEAK▾
S&P3
ROA?-31.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-208276000
Enterprise Value?$-213282227
Fundamentals ratios updated end of day